CanAm Scientific – Page 2 – Sonablate HIFU MEA

July 6, 2022

Three separate clinicians told Paul Sayer that focal therapy was not an option for his prostate disease. Turns out, that was not true.

0 Comments6 Minutes

June 18, 2022

Sonablate Corp. Announces Support for Centers for Medicare & Medicaid Services (CMS) proposed increase in reimbursement rates for Sonablate HIFU procedure

0 Comments3 Minutes

June 2, 2022

Sonablate Corp. Receives NMPA Approval in China to treat Benign Prostatic Hyperplasia(BPH)

0 Comments2 Minutes

January 18, 2022

Sonablate Corp. signed exclusive distribution agreement with CanAm Scientific for the GCC Territory

0 Comments4 Minutes

August 15, 2021

Sonablate Corp announces formation, over $70m in combined seed investment and distribution agreement

0 Comments4 Minutes

August 15, 2021

Sonacare medical announces significant publication of focal therapy comparison to radical therapy

0 Comments5 Minutes

August 15, 2021

Sonacare medical announces purchase at Mayo Clinic

0 Comments5 Minutes